Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery
Open Access
- 25 November 2020
- journal article
- Published by Peertechz Publications Private Limited in Journal of Cardiovascular Medicine and Cardiology
- Vol. 7 (4), 293-295
- https://doi.org/10.17352/2455-2976.000155
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox®) anticoagulationPerfusion, 2017
- Heparin-Induced Thrombocytopenia in Cardiac Surgery PatientsSeminars in Thrombosis and Hemostasis, 2017
- Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer LookClinical and Applied Thrombosis/hemostasis, 2016
- A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The EVOLUTION-ON studyThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced ThrombocytopeniaAnesthesia & Analgesia, 2004
- Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgeryThe Annals of Thoracic Surgery, 2004
- Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingThe American Journal of Cardiology, 2004
- The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopeniaThe Annals of Thoracic Surgery, 2001
- Heparin-Induced ThrombocytopeniaJournal of Invasive Cardiology, 1998